| 輔英科技大學 |
2009-08-01 |
High-dose Bisacodyl Plus Water Lavage Compared With Oral Sodium Phosphate as Bowel Preparation for Outpatient Colonoscopy
|
Tai-An Chen; Hsin-Yung Wong; Chiun-Ku Lin; Hsien-Chung Yu; Ping-I Hsu; Gin-Ho Lo; Kwok-Hung Lai |
| 國立成功大學 |
2017-08 |
High-dose calcineurin inhibitor-free everolimus as a maintenance regimen for heart transplantation may be a risk factor for Pneumocystis pneumonia
|
Hu;Yu-Ning;Lee;Nan-Yao;Roan;Jun-Neng;Hsu;Chi-Hsin;Luo;Chwan-Yau |
| 國立成功大學 |
2003-07 |
High-dose chemotherapy and hematopoietic stem cell transplantation for patients with nasopharyngeal cancer: a feasibility study
|
Chen, Tsai-Yun; Chen, HelenH. W.; Su, Wu-Chou; Tsao, Chao-Jung |
| 臺大學術典藏 |
2018-09-10T04:04:31Z |
High-dose chemotherapy with support by autologous bone marrow and GM-CSF in the treatment of advanced ovarian cancer: Preliminary report of a new strategy
|
Yen, M.-L. and Chen, Y.-C. and Lin, M.-T. and Liu, M.-C. and Tang, J.-L. and Wang, C.-H. and Hsieh, C.-Y.; MEN-LUH YEN |
| 臺大學術典藏 |
1992 |
High-dose chemotherapy with support by autologous bone marrow and GM-CSF in the treatment of advanced ovarian cancer: Preliminary report of a new strategy
|
MEN-LUH YEN; Chen Y.-C; Lin M.-T; Liu M.-C; Tang J.-L; Wang C.-H; Hsieh C.-Y. |
| 臺大學術典藏 |
2020-02-11T01:44:01Z |
High-dose chemotherapy with support by autologous bone marrow and GM-CSF in the treatment of advanced ovarian cancer: Preliminary report of a new strategy
|
Men-Luh Yen;Chen Y.-C;Lin M.-T;Liu M.-C;Tang J.-L;Wang C.-H;Hsieh C.-Y.; MEN-LUH YEN; Chen Y.-C; Lin M.-T; Liu M.-C; Tang J.-L; Wang C.-H; Hsieh C.-Y. |
| 臺大學術典藏 |
2020-11-27T08:14:57Z |
High-dose chemotherapy with support by autologous bone marrow and GM-CSF in the treatment of advanced ovarian cancer: Preliminary report of a new strategy
|
Yen M.-L.;Chen Y.-C.;Lin M.-T.;Liu M.-C.;Tang J.-L.;Wang C.-H.;Chang-Yao Hsieh; Yen M.-L.; Chen Y.-C.; Lin M.-T.; Liu M.-C.; Tang J.-L.; Wang C.-H.; CHANG-YAO HSIEH |
| 臺大學術典藏 |
2021-01-06T03:59:08Z |
High-dose chemotherapy with support by autologous bone marrow and GM-CSF in the treatment of advanced ovarian cancer: Preliminary report of a new strategy
|
Yen M.-L.; Chen Y.-C.; Lin M.-T.; Liu M.-C.; JIH-LUH TANG; Wang C.-H.; Hsieh C.-Y. |
| 國立臺灣大學 |
1992 |
High-Dose Chemotherapy with Support by Autologous Bone Marrow and GM-CSF in the Treatment of Advanced Ovarian:Preliminary Report of a New Strategy
|
嚴孟祿; Chen, Y. C.; Lin, M. T.; Liu, M. C.; Tang, J. L.; Wang, C. H.; 謝長堯; Yen, Men-Lun; Chen, Y. C.; Lin, M. T.; Liu, M. C.; Tang, J. L.; Wang, C. H.; Hsieh, Chang-Yao |
| 臺大學術典藏 |
2022-04-25T06:12:28Z |
High-dose copper activates p53-independent apoptosis through the induction of nucleolar stress in human cell lines
|
Chen C.-H;Chou Y.-T;Yang Y.-W;Lo K.-Y.; Chen C.-H; Chou Y.-T; Yang Y.-W; Lo K.-Y.; KAI-YIN LO |
| 臺大學術典藏 |
2022-07-21T06:02:23Z |
High-dose copper activates p53-independent apoptosis through the induction of nucleolar stress in human cell lines
|
Chen, Chieh-Hsin; Chou, Yi-Ting; YA-WEN YANG; Lo, Kai-Yin |
| 國立臺灣大學 |
2015 |
High-dose Dual Therapy Is Superior to Standard First-line or Rescue Therapy for Helicobacter pylori Infection
|
Yang, Jyh-Chin; Lin, Chun-Jung; Wang, Hong-Long; Chen, Jin-De; Kao, John Y.; Shun, Chia-Tung; Lu, Chien-Wei; Lin, Bor-Ru; Shieh, Ming-Jium; Chang, Ming-Chu; Chang, Yu-Ting; Wei, Shu-Chen; Lin, Lin-Chih; Yeh, Wen-Chun; Kuo, Jen-Shin; Tung, Chien-Chih; Leong, Yew-Loong; Wang, Teh-Hong; Wong, Jau-Min; 王德宏; 謝銘鈞; 董建志; 楊智欽; 翁昭旼; 章明珠; 魏淑?; 張毓廷; 孫家棟; 林伯儒; 林君榮 |
| 臺大學術典藏 |
2018-09-10T15:26:48Z |
High-dose dual therapy is superior to standard first-line or rescue therapy for helicobacter pylori infection
|
Yang, J.-C. and Lin, C.-J. and Wang, H.-L. and Chen, J.-D. and Kao, J.Y. and Shun, C.-T. and Lu, C.-W. and Lin, B.-R. and Shieh, M.-J. and Chang, M.-C. and Chang, Y.-T. and Wei, S.-C. and Lin, L.-C. and Yeh, W.-C. and Kuo, J.-S. and Tung, C.-C. and Leong, Y.-L. and Wang, T.-H. and Wong, J.-M.; Yang, Jyh-Chin;Lin, Chun-Jung;Wang, Hong-Long;Chen, Jin-De;Kao, John Y.;Shun, Chia-Tung;Lu, Chien-Wei;Lin, Bor-Ru;Shieh, Ming-Jium;Chang, Ming-Chu;Chang, Yu-Ting;Wei, Shu-Chen;Lin, Lin-Chih;Yeh, Wen-Chun;Kuo, Jen-Shin;Tung, Chien-Chih;Leong, Yew-Loong;Wang, Teh-Hong;Wong, Jau-Min; 王德宏;謝銘鈞;董建志;楊智欽;翁昭旼;章明珠;魏淑?;張毓廷;孫家棟;林伯儒;林君榮; Hsieh, Yi-Ping; CHUN-JUNG LIN; Yang, Jyh-Chin; YU-TING CHANG; Shen, April Chiung-Tao; Lin, Chun-Jung; Wang, Hong-Long; Wei, Hsi-Sheng; JYH-CHIN YANG; CHIA-TUNG SHUN; Chen, Jin-De; Feng, Jui-Ying; Huang, Soar Ching-Yu; Kao, John Y.; BOR-RU LIN; Hwa, Hsiao-Lin; Shun, Chia-Tung; Lu, Chien-Wei; Lin, Bor-Ru; Shieh, Ming-Jium; Chang, Ming-Chu; Chang, Yu-Ting; Wei, Shu-Chen; Lin, Lin-Chih; Yeh, Wen-Chun; Kuo, Jen-Shin; Tung, Chien-Chih; Leong, Yew-Loong; Wang, Teh-Hong; Wong, Jau-Min; 華筱玲 |
| 臺大學術典藏 |
2020-08-07T01:43:05Z |
High-dose dual therapy is superior to standard first-line or rescue therapy for helicobacter pylori infection
|
Lin B.-R.; Shieh M.-J.; Chang M.-C.; Chang Y.-T.; Wei S.-C.; Lu C.-W.; Shun C.-T.; Yang J.-C.; Lin C.-J.; Wang H.-L.; Chen J.-D.; Kao J.Y.; Leong Y.-L.; Wang T.-H.; Wong J.-M.; Lin L.-C.; Yeh W.-C.; Kuo J.-S.; CHIEN-CHIH TUNG |
| 臺大學術典藏 |
2020-10-14T07:24:41Z |
High-dose dual therapy is superior to standard first-line or rescue therapy for helicobacter pylori infection
|
Wang T.-H.; Tung C.-C.; Leong Y.-L.; Kuo J.-S.; Yeh W.-C.; Yang J.-C.; Lin C.-J.; Wang H.-L.; Chen J.-D.; Kao J.Y.; Shun C.-T.; Lu C.-W.; Lin B.-R.; Shieh M.-J.; Chang M.-C.; Chang Y.-T.; SHU-CHEN WEI; Lin L.-C.; Wong J.-M. |
| 臺大學術典藏 |
2021-02-04T07:16:09Z |
High-dose dual therapy is superior to standard first-line or rescue therapy for helicobacter pylori infection
|
Yang J.-C.; Lin C.-J.; Wang H.-L.; Chen J.-D.; Kao J.Y.; Shun C.-T.; Lu C.-W.; Lin B.-R.; Shieh M.-J.; Chang M.-C.; YU-TING CHANG; Wei S.-C.; Lin L.-C.; Yeh W.-C.; Kuo J.-S.; Tung C.-C.; Leong Y.-L.; Wang T.-H.; Wong J.-M. |
| 臺大學術典藏 |
2021-05-27T02:50:08Z |
High-dose dual therapy is superior to standard first-line or rescue therapy for helicobacter pylori infection
|
JYH-CHIN YANG; Lin C.-J.; Wang H.-L.; Chen J.-D.; Kao J.Y.; Shun C.-T.; Lu C.-W.; Lin B.-R.; Shieh M.-J.; Chang M.-C.; Chang Y.-T.; Wei S.-C.; Lin L.-C.; Yeh W.-C.; Kuo J.-S.; Tung C.-C.; Leong Y.-L.; Wang T.-H.; Wong J.-M. |
| 臺大學術典藏 |
2021-06-04T03:09:10Z |
High-dose dual therapy is superior to standard first-line or rescue therapy for helicobacter pylori infection
|
Yang J.-C.;Chun-Jung Lin;Wang H.-L.;Chen J.-D.;Kao J.Y.;Shun C.-T.;Lu C.-W.;Lin B.-R.;Shieh M.-J.;Chang M.-C.;Chang Y.-T.;Wei S.-C.;Lin L.-C.;Yeh W.-C.;Kuo J.-S.;Tung C.-C.;Leong Y.-L.;Wang T.-H.;Wong J.-M.; Yang J.-C.; CHUN-JUNG LIN; Wang H.-L.; Chen J.-D.; Kao J.Y.; Shun C.-T.; Lu C.-W.; Lin B.-R.; Shieh M.-J.; Chang M.-C.; Chang Y.-T.; Wei S.-C.; Lin L.-C.; Yeh W.-C.; Kuo J.-S.; Tung C.-C.; Leong Y.-L.; Wang T.-H.; Wong J.-M. |
| 臺大學術典藏 |
2021-06-15T03:12:06Z |
High-dose dual therapy is superior to standard first-line or rescue therapy for helicobacter pylori infection
|
Yang J.-C.; Lin C.-J.; Wang H.-L.; Chen J.-D.; Kao J.Y.; Shun C.-T.; Lu C.-W.; Lin B.-R.; Shieh M.-J.; Chang M.-C.; Chang Y.-T.; SHU-CHEN WEI; Lin L.-C.; Yeh W.-C.; Kuo J.-S.; Tung C.-C.; Leong Y.-L.; Wang T.-H.; Wong J.-M. |
| 臺大學術典藏 |
2022-03-04T08:22:45Z |
High-dose dual therapy is superior to standard first-line or rescue therapy for helicobacter pylori infection
|
JYH-CHIN YANG; Lin C.-J.; Wang H.-L.; Chen J.-D.; Kao J.Y.; Shun C.-T.; Lu C.-W.; Lin B.-R.; Shieh M.-J.; Chang M.-C.; Chang Y.-T.; Wei S.-C.; Lin L.-C.; Yeh W.-C.; Kuo J.-S.; Tung C.-C.; Leong Y.-L.; Wang T.-H.; Wong J.-M. |
| 臺大學術典藏 |
2021-02-02T08:29:45Z |
High-dose dual therapy is superior to standard first-line or rescue therapy for helicobacter pylori infection
|
Yang J.-C.; Lin C.-J.; Wang H.-L.; Chen J.-D.; Kao J.Y.; Shun C.-T.; Lu C.-W.; BOR-RU LIN; Shieh M.-J.; Chang M.-C.; Chang Y.-T.; Wei S.-C.; Lin L.-C.; Yeh W.-C.; Kuo J.-S.; Tung C.-C.; Leong Y.-L.; Wang T.-H.; Wong J.-M. |
| 臺大學術典藏 |
2021-03-05T06:07:21Z |
High-dose dual therapy is superior to standard first-line or rescue therapy for helicobacter pylori infection
|
Yang J.-C.; Lin C.-J.; Wang H.-L.; Chen J.-D.; Kao J.Y.; Shun C.-T.; Lu C.-W.; Lin B.-R.; Shieh M.-J.; MING-CHU CHANG; Chang Y.-T.; Wei S.-C.; Lin L.-C.; Yeh W.-C.; Kuo J.-S.; Tung C.-C.; Leong Y.-L.; Wang T.-H.; Wong J.-M. |
| 臺大學術典藏 |
2021-03-18T02:02:41Z |
High-dose dual therapy is superior to standard first-line or rescue therapy for helicobacter pylori infection
|
Yang J.-C.;Lin C.-J.;Wang H.-L.;Chen J.-D.;Kao J.Y.;Chia-Tung Shun;Lu C.-W.;Lin B.-R.;Shieh M.-J.;Chang M.-C.;Chang Y.-T.;Wei S.-C.;Lin L.-C.;Yeh W.-C.;Kuo J.-S.;Tung C.-C.;Leong Y.-L.;Wang T.-H.;Wong J.-M.; Yang J.-C.; Lin C.-J.; Wang H.-L.; Chen J.-D.; Kao J.Y.; CHIA-TUNG SHUN; Lu C.-W.; Lin B.-R.; Shieh M.-J.; Chang M.-C.; Chang Y.-T.; Wei S.-C.; Lin L.-C.; Yeh W.-C.; Kuo J.-S.; Tung C.-C.; Leong Y.-L.; Wang T.-H.; Wong J.-M. |
| 臺大學術典藏 |
2020-02-27T06:39:29Z |
High-dose dual therapy is superior to standard first-line or rescue therapy for helicobacter pylori infection
|
Yang J.-C.;Lin C.-J.;Wang H.-L.;Chen J.-D.;Kao J.Y.;Shun C.-T.;Lu C.-W.;Lin B.-R.;Ming-Jium Shieh;Chang M.-C.;Chang Y.-T.;Wei S.-C.;Lin L.-C.;Yeh W.-C.;Kuo J.-S.;Tung C.-C.;Leong Y.-L.;Wang T.-H.;Wong J.-M.; Yang J.-C.; Lin C.-J.; Wang H.-L.; Chen J.-D.; Kao J.Y.; Shun C.-T.; Lu C.-W.; Lin B.-R.; MING-JIUM SHIEH; Chang M.-C.; Chang Y.-T.; Wei S.-C.; Lin L.-C.; Yeh W.-C.; Kuo J.-S.; Tung C.-C.; Leong Y.-L.; Wang T.-H.; Wong J.-M. |
| 國立臺灣大學 |
2013 |
High-dose hypofractionated X-ray radiotherapy for hepatocellular carcinoma: Tumor responses and toxicities
|
Huang, Bing-Shen; Tsang, Ngan-Ming; Lin, Shi-Ming; Lin, Deng-Yn; Lien, Jau-Min; Lin, Chen-Chun; Chen, Wei-Ting; Chen, Wan-Yu; Hong, Ji-Hong; 陳婉瑜 |
| 臺大學術典藏 |
2020-07-17T03:46:02Z |
High-dose hypofractionated X-ray radiotherapy for hepatocellular carcinoma: Tumor responses and toxicities
|
J.H. Hong; WAN-YU CHEN; W.T. Chen; C.C. Lin; J.M. Lien; D.Y. Lin; S.M. Lin; Huang B.S; N.M. Tsang |
| 國立成功大學 |
2003-03 |
High-dose interferon-α2b plus ribavirin combination therapy for GB virus-C/hepatitis G virus infection-a study in patients with chronic hepatitis C
|
Cheng, �Pin-Nan; Jen, �Chung-Min; Young, �Kung-Chia; Chen, �Chi-Yi; Lu, �Sheng-Nan; Wang, �Chong-Shan; Chang, Ting-Tsung |
| 國立成功大學 |
2007-03 |
High-dose morphine impairs vascular endothelial function by increased production of superoxide anions
|
Lam, Chen-Fuh; Liu, Yen-Chin; Tseng, Fan-Ling; Sung, Yen-Hui; Huang, Chien-Chi; Jiang, Meei-Jyh; Tsai, Yu-Chuan |
| 國立成功大學 |
2002-03 |
High-dose steroid pulse therapy for the treatment of severe alopecia areata
|
Tsai, Ya-Ming; Chen, WenChieh; Hsu, Mark Ming-Long; Lin, Tzu-Kai |
| 國立臺灣大學 |
2003 |
High-Dose Tamoxifen Modulates Drug Resistance to Doxorubicin, Dacarbazine and Ifosfamide in Metastatic Uterine Leiomyosarcoma
|
葉坤輝; 盧彥伸; 蕭正祥; 鄭安理; YEH, KUN-HUEI; LU, YEN-SHEN; HSIAO, CHENG-HSIANG; CHENG, ANN-LII |
| 臺大學術典藏 |
2018-09-10T04:27:00Z |
High-dose Tamoxifen Modulates Drug Resistance to Doxorubicin, Dacarbazine and Ifosfamide in Metastatic Uterine Leiomyosarcoma
|
Yeh, K.-H. and Lu, Y.-S. and Hsiao, C.-H. and Cheng, A.-L.; KUN-HUEI YEH |
| 臺大學術典藏 |
2020-05-25T06:52:10Z |
High-dose Tamoxifen Modulates Drug Resistance to Doxorubicin, Dacarbazine and Ifosfamide in Metastatic Uterine Leiomyosarcoma
|
Cheng A.-L.;Hsiao C.-H;Yen-Shen Lu;Yeh K.-H; Yeh K.-H; YEN-SHEN LU; Hsiao C.-H; Cheng A.-L. |
| 臺大學術典藏 |
2021-01-28T01:06:51Z |
High-dose Tamoxifen Modulates Drug Resistance to Doxorubicin, Dacarbazine and Ifosfamide in Metastatic Uterine Leiomyosarcoma
|
Kun-Huei Yeh;Lu Y.-S.;Hsiao C.-H.;Cheng A.-L.; KUN-HUEI YEH; Lu Y.-S.; Hsiao C.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2021-09-01T02:02:22Z |
High-dose Tamoxifen Modulates Drug Resistance to Doxorubicin, Dacarbazine and Ifosfamide in Metastatic Uterine Leiomyosarcoma
|
Yeh K.-H.; Lu Y.-S.; Hsiao C.-H.; ANN-LII CHENG |
| 國立臺灣大學 |
2013 |
High-dose Tamoxifen plus Ifosfamide and Anthracycline in a Patient with Angiosarcoma of the Breast
|
Hsiao, C-H; Yeh, K-H; Chang, Y-C; Tsai, C-C; 葉坤輝 |
| 臺大學術典藏 |
2021-01-28T01:06:38Z |
High-dose tamoxifen plus ifosfamide and anthracycline in a patient with angiosarcoma of the breast
|
Hsiao C.-H.;Kun-Huei Yeh;Chang Y.-C.;Tsai C.-C.; Hsiao C.-H.; KUN-HUEI YEH; Chang Y.-C.; Tsai C.-C. |
| 臺大學術典藏 |
1997 |
High-dose tamoxifen reverses drug resistance to cisplatin and etoposide in a patient with advanced large cell carcinoma of lung
|
Yeh, K.-H. and Cheng, A.-L.; KUN-HUEI YEH |
| 臺大學術典藏 |
2021-01-28T01:07:00Z |
High-dose tamoxifen reverses drug resistance to cisplatin and etoposide in a patient with advanced large cell carcinoma of lung
|
Kun-Huei Yeh;Cheng A.-L.; KUN-HUEI YEH; Cheng A.-L. |
| 臺大學術典藏 |
2021-09-01T02:02:39Z |
High-dose tamoxifen reverses drug resistance to cisplatin and etoposide in a patient with advanced large cell carcinoma of lung
|
Yeh K.-H.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-01-06T03:59:02Z |
High-dose therapy with peripheral blood stem cell (PBSC) support using an innovative mobilization regimen in patients with high-risk primary or chemoresponsive metastatic breast cancers
|
Yeh K.-H.; Lin M.-T.; Lin D.-T.; JIH-LUH TANG; Lui L.-T.; Lin J.-F.; Chang Y.-S.; Cheng A.-L.; Yu S.-C.; Chang K.-J.; Chen Y.-C. |
| 臺大學術典藏 |
2021-09-01T02:02:36Z |
High-dose therapy with peripheral blood stem cell (PBSC) support using an innovative mobilization regimen in patients with high-risk primary or chemoresponsive metastatic breast cancers
|
Yeh K.-H.; Lin M.-T.; Lin D.-T.; Tang J.-L.; Lui L.-T.; Lin J.-F.; Chang Y.-S.; ANN-LII CHENG; Yu S.-C.; Chang K.-J.; Chen Y.-C. |
| 臺大學術典藏 |
2021-01-28T01:06:56Z |
High-dose therapy with peripheral blood stem cell (PBSC) support using an innovative mobilization regimen in patients with high-risk primary or chemoresponsive metastatic breast cancers
|
KUN-HUEI YEH; Lin M.-T.; Lin D.-T.; Tang J.-L.; Lui L.-T.; Lin J.-F.; Chang Y.-S.; Cheng A.-L.; Yu S.-C.; Chang K.-J.; Chen Y.-C. |
| 臺大學術典藏 |
2021-05-26T09:08:24Z |
High-dose therapy with peripheral blood stem cell (PBSC) support using an innovative mobilization regimen in patients with high-risk primary or chemoresponsive metastatic breast cancers
|
Yeh K.-H.; Lin M.-T.; Lin D.-T.; Tang J.-L.; Lui L.-T.; Lin J.-F.; Chang Y.-S.; Cheng A.-L.; Yu S.-C.; Chang K.-J.; YAO-CHANG CHEN |
| 臺大學術典藏 |
2022-08-12T06:29:03Z |
High-dose therapy with peripheral blood stem cell (PBSC) support using an innovative mobilization regimen in patients with high-risk primary or chemoresponsive metastatic breast cancers
|
Yeh K.-H.; Lin M.-T.; Lin D.-T.; Tang J.-L.; Lui L.-T.; Lin J.-F.; Chang Y.-S.; Cheng A.-L.; Yu S.-C.; KING-JEN CHANG; Chen Y.-C. |
| 國立臺灣大學 |
1998 |
High-Dose Therapy with Peripheral Blood Stem Cells (Pbscs) Support Using an Innovative Mobilization Regimen in Patients with High-Risk Primary or Chemoresponsive Metastatic Breast Cancers
|
葉坤輝; 林敏哲; 林東燦; 唐季祿; 雷德; 林靜芳; 張玉憲; 鄭安理; 張金堅; 陳耀昌; YEH, KUN-HUEI; LIN, MING-TSEH; LIN, DONG-TSAMN; TANG, JIH-LUH; LUI, LOUIS TAK; LIN, JING-FANG; CHANG, YU-SHIAHN; CHENG, ANN-LII; CHANG, KING-JEN; CHEN, YAO-CHANG |
| 臺北醫學大學 |
2007 |
High-dose vascular endothelial growth factor increases surfactant protein gene expressions in preterm rat lung
|
汪棱芳; Chen CM; Wang LF |
| 臺北醫學大學 |
2007-09 |
High-dose vascular endothelial growth factor increases surfactant protein gene expressions in preterm rat lung.
|
陳中明; Chen CM; Wang LF |
| 國立成功大學 |
2023-05 |
High-dose vitamin C-induced acute oxalate nephropathy in a renal transplant recipient: A case report and literature review
|
Shen;Zong-Yu;Chen;Ying-Ren;Wang;Ming-Cheng;Chang;Shen-Shin |
| 臺大學術典藏 |
2018-09-10T08:03:18Z |
High-dose vs non-high-dose proton pump inhibitors after endoscopic treatment in patients with bleeding peptic ulcer: A systematic review and meta-analysis of randomized controlled trials
|
Wang, C.-H. and Ma, M.H.-M. and Chou, H.-C. and Yen, Z.-S. and Yang, C.-W. and Fang, C.-C. and Chen, S.-C.; MATTHEW HUEI-MING MA; CHIH-HUNG WANG; CHENG-CHUNG FANG; CHIH-WEI YANG; SHYR-CHYR CHEN; ZUI-SHEN YEN |
| 臺大學術典藏 |
2020-12-07T07:11:51Z |
High-dose vs non-high-dose proton pump inhibitors after endoscopic treatment in patients with bleeding peptic ulcer: A systematic review and meta-analysis of randomized controlled trials
|
Wang C.-H.; Ma M.H.-M.; Chou H.-C.; Yen Z.-S.; Yang C.-W.; Fang C.-C.; SHYR-CHYR CHEN |
